Status:
UNKNOWN
Effects of Intensive Lipid Lowering and Omega-3 Fatty Acid on Composition of Coronary Atherosclerotic Plaque
Lead Sponsor:
Samsung Medical Center
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether intensive lipid lowering and Omega-3 fatty acid are effective in the treatment of coronary atherosclerotic plaque.
Eligibility Criteria
Inclusion
- Acute coronary syndrome within 48 hours of symptom onset
- Have de novo non-culprit coronary artery stenosis 20% to 70% by visual estimation
Exclusion
- Cardiogenic shock
- ST segment elevation myocardial infarction within 1 week
- Hematologic disorder: neutropenia (neutrophil\<3000/mm3), thrombocytopenia (platelet\<100,000/mm3)
- Liver enzyme elevation: serum aspartate aminotransferase or alanine aminotransferase concentrations more than 3 times the upper limit of normal
- Impaired renal function with serum creatinine \> 2mg/dL
- Bleeding diathesis or history of coagulopathy
- Pregnancy
- Hypersensitivity to heparin, dye, aspirin, clopidogrel, statin, or fish
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00760786
Start Date
July 1 2008
Last Update
September 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cardiac and Vascular Center; Samsung Medical Center
Seoul, South Korea, 135-710